title: [Molecular target therapy for myelodysplastic syndrome].
authors.affiliation: Department of Hematology and Rheumatology, Kinki University Faculty of Medicine.
authors.forename: Yasuyoshi
authors.initials: Y
authors.lastname: Morita
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Tanaka
authors.forename: Itaru
authors.initials: I
authors.lastname: Matsumura
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016207:Cytokines / Q000037:antagonists & inhibitors; D000077209:Decitabine; D044127:Epigenesis, Genetic; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use; D006801:Humans; D000077269:Lenalidomide; D058990:Molecular Targeted Therapy / Q000379:methods*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D000964:Antimetabolites, Antineoplastic; D016207:Cytokines; D056572:Histone Deacetylase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D013792:Thalidomide; D000077209:Decitabine; D000077269:Lenalidomide; D001374:Azacitidine